NasdaqGM - Delayed Quote USD
Fulcrum Therapeutics, Inc. (FULC)
7.11
+0.08
+(1.14%)
At close: June 5 at 4:00:01 PM EDT
7.11
0.00
(0.00%)
After hours: June 5 at 4:04:10 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | -0.29 | -0.7 | -1.17 | -1.18 |
| Low Estimate | -0.31 | -3.1 | -1.22 | -1.31 |
| High Estimate | -0.28 | -0.28 | -1.09 | -1.04 |
| Year Ago EPS | 0.87 | -0.46 | -0.12 | -1.17 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 6 | 7 | 7 |
| Avg. Estimate | -- | -- | -- | 222.78k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 1.56M |
| Year Ago Sales | 80M | -- | 80M | -- |
| Sales Growth (year/est) | -100.00% | 0.00% | -100.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.06 | -0.4 | -0.29 | -0.32 |
| EPS Actual | 0.87 | -0.46 | -0.31 | -0.28 |
| Difference | 0.81 | -0.07 | -0.02 | 0.04 |
| Surprise % | 1,250.09% | -16.55% | -7.52% | 13.85% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.29 | -0.7 | -1.17 | -1.18 |
| 7 Days Ago | -0.29 | -0.7 | -1.17 | -1.16 |
| 30 Days Ago | -0.31 | -0.31 | -1.25 | -1.19 |
| 60 Days Ago | -0.31 | -0.31 | -1.25 | -1.19 |
| 90 Days Ago | -0.31 | -0.31 | -1.26 | -1.19 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | 1 |
| Up Last 30 Days | 1 | 2 | 4 | 3 |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FULC | -133.83% | -50.16% | -845.44% | -1.22% |
| S&P 500 | 13.12% | 2.46% | 7.55% | 13.98% |
Upgrades & Downgrades
| Maintains | Piper Sandler: Overweight to Overweight | 5/29/2025 |
| Upgrade | Leerink Partners: Market Perform to Outperform | 5/23/2025 |
| Upgrade | Cantor Fitzgerald: Neutral to Overweight | 5/15/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 2/26/2025 |
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 11/14/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 11/14/2024 |
Related Tickers
MAZE Maze Therapeutics, Inc.
13.34
-3.82%
COGT Cogent Biosciences, Inc.
5.99
+6.21%
RAPT RAPT Therapeutics, Inc.
1.0200
0.00%
BCYC Bicycle Therapeutics plc
8.50
+0.47%
CLYM Climb Bio Inc
1.2400
-3.88%
CGEM Cullinan Therapeutics, Inc.
8.74
-3.64%
ATXS Astria Therapeutics, Inc.
5.22
-1.14%
IDYA IDEAYA Biosciences, Inc.
21.10
0.00%
ZURA Zura Bio Limited
1.1500
-2.54%
PRAX Praxis Precision Medicines, Inc.
42.26
+2.15%